OKYO Pharma Ltd - ESG Rating & Company Profile powered by AI
This page includes a Q&A section about OKYO Pharma Ltd. The analysis of OKYO Pharma Ltd was prepared by All Street Sevva using advanced AI. Check the bottom of this webpage for potential risks for OKYO Pharma Ltd based on industry, location and size.
OKYO Pharma Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.6; made up of an environmental score of 5.3, social score of 6.4 and governance score of 8.0.
6.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 337 | Sonoma Pharmaceuticals Inc | 6.7 | High |
| 337 | Zhong Yuan Bio-Technology Holdings Ltd | 6.7 | High |
| 389 | OKYO Pharma Ltd | 6.6 | High |
| 389 | Austar Lifesciences Ltd | 6.6 | High |
| 389 | Alligator Bioscience AB | 6.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does OKYO Pharma Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes OKYO Pharma Ltd report the average age of the workforce?
Sign up for free to unlockDoes OKYO Pharma Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes OKYO Pharma Ltd offer flexible work?
Sign up for free to unlockDoes OKYO Pharma Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes OKYO Pharma Ltd conduct supply chain audits?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes OKYO Pharma Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose water use targets?
Sign up for free to unlockDoes OKYO Pharma Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid OKYO Pharma Ltd have a product recall in the last two years?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes OKYO Pharma Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas OKYO Pharma Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose parental leave metrics?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes OKYO Pharma Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes OKYO Pharma Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs OKYO Pharma Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose its waste policy?
Sign up for free to unlockDoes OKYO Pharma Ltd report according to TCFD requirements?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose energy use targets?
Sign up for free to unlockDoes OKYO Pharma Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes OKYO Pharma Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for OKYO Pharma Ltd
These potential risks are based on the size, segment and geographies of the company.
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.